FSC has approved the merger of Bulgarian Rose-Sevtopolis in Sopharma

The stocks of Bulgarian Rose - Sevtopolis will probably be traded on the stock exchange until 3 December

On Friday, the Financial Supervision Commission (FSC) approved the Agreement for the merger of Bulgarian Rose-Sevtopolis AD in Sopharma AD, announced from Sopharma in the Investor.bg bulletin.

In connection with this merger, the capital of Sopharma will be increased from 132 mln. levs to 134 798 527 levs by the issue of 2 798 527 new ordinary shares of 1 lev par value each.

For one of their shares from Bulgarian Rose-Sevtopolis, every shareholder of the Company will acquire 0,463768 shares from Sopharma. Bulgarian Rose – Sevtopolis will be terminated without liquidation, and its entire property will pass to the successor Sopharma.

Extraordinary General Meetings of both companies are forthcoming, and the deadline for entry of the transformation in the Commercial Register is 12 February 2015. Bulgarian Rose – Sevtopolis will file an application to FSC for suspension of trading with the Company's shares after completion of the session on 3 December.

Source: Investor.bg